Conditioning as Part of Immunotherapy

Immunotherapy Method

The practice of conditioning refers to administering immunosuppressive agents or low-dose chemotherapeutic agent as part of anti-cancer immunotherapy procedures, before the activation of the patient’s immune system or the administration of activated donor lymphocytes. However, it should be noted that chemotherapy can induce both mild anti-cancer cytotoxicity, suppress some negative regulators of the immune system, and deplete a patient’s lymphocytes that are tolerant and non-reactive against patient’s cancer cells. At the same time, they may provide space or a “niche” for patient’s or donor’s newly derived lymphocytes.

In other words, conditioning prior to immunotherapy is designed to fulfil three requirements:

  1. To create room for the donated cells that are about to be infused
  2. To eliminate the patient’s non-responding lymphocytes
  3. To deplete any suppressive regulatory T-cells or other suppressor cells.

What is Homeostatic Proliferation?

The concept of homeostatic proliferation is the body’s natural tendency to keep a steady level of T-cells. In this way, if the level of the patient’s lymphocytes is reduced, it will induce rapid production of newly-generated T cells that may be educated to react against cancer and/or will provide infused donor lymphocytes with more space and an advantage. In turn, this will avoid the dilution of effective anti-cancer killer cells with ineffective, naive patients lymphocytes that also includes different types of suppressor cells.


Contact Us

If it is convenient for you, describe your problem in the message, and we will answer you.

    Weizmann 14, Tel Aviv, Israel